|
Characteristics | Therapeutic success, frequency (%)* | Therapeutic failure, frequency (%)* | B | 95% CI | P |
| Average age | 31.4 ± 5.05 | 31.1 ± 0.15 | 0.72 | −0.98, 2.52 | 0.41 |
| Parity |
|
|
|
|
|
| Primipara Multipara | 31 (38.8) 49 (61.3) | 7 (46.7) 8 (53.3) | −1.62 0.73 | −0.98, 2.52 −0.86, 2.48 | 0.25 0.38 |
| Gestational age |
|
|
|
|
|
| 4 - 11+6 w 12 - 27+6 w ≥28 w | 70 (87.5) 5 (6.3) 5 (6.3) | 10 (66.7) 1 (6.7) 4 (26.7) | 0.92 −0.58 −2.41 | −2.66, 2.55 −3.18, 2.71 −4.42, −0.49 | 0.76 0.68 0.01† |
| Others |
|
|
|
|
|
| Anemia | 36 (45) | 4 (26.7) | 1.32 | −0.26, 3.24 | 0.13 |
| GDM | 10 (12.5) | 3 (20.0) | −0.67 | −2.29, 1.12 | 0.43 |
| History of UTI | 6 (7.5) | 4 (26.7) | −0.50 | −2.51, 1.70 | 0.63 |
| Symptomatic | 6 (7.5) | 6 (40) | −2.74 | −4.81, −0.96 | 0.004† |